logo
Share SHARE
FONT-SIZE Plus   Neg

Chelsea To Discuss NORTHERA NDA For Treatment Of Symptomatic Neurogenic OH

Chelsea Therapeutics International, Ltd. (CHTP) said it will meet with the Food and Drug Administration's, or FDA's, Cardiovascular and Renal Drugs Advisory Committee on February 23, 2012 to review clinical data in support of the New Drug Application, or NDA, for NORTHERA (droxidopa).

Chelsea is seeking approval of NORTHERA for treating symptomatic neurogenic orthostatic hypotension, or Neurogenic OH, in patients with primary autonomic failure, dopamine beta hydroxylase deficiency and non-diabetic autonomic neuropathy.

Dr. Simon Pedder, president and CEO of Chelsea, stated, "We have closely reviewed the materials prepared by the FDA, and look forward to presenting our clinical data to the Advisory Committee, which we believe will address the questions raised by the FDA. We believe that our clinical program has established robust safety and efficacy data for NORTHERA in this patient population."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Ryanair Holdings Plc pilots have rejected a cash bonus offered to them by the airline in exchange for cancelling their leave as the airline grapples with massive flight cancellations. Ryanair is cancelling 40 to 50 flights daily for the next six weeks, till the end of October, after it admitted to having "messed up" the planning of pilot holidays. Taco Bell, which records majority of its revenues from drive-thru windows, reportedly plans to open hundreds of new locations without a drive-thru by 2022, so it can finally sell more booze. The Tex-Mex brand plans to open 300 to 350 locations of new drive-thru-less cantinas by 2022 as it aims to make its presence known in urban areas, the reports said. Amazon.com may be talking with some middle-market pharmacy benefit managers or PBMs looking for various contractual arrangements, Axios reported, citing analysts at investment bank Leerink Partners. As per the report, the e-commerce giant, which recently entered the grocery industry with the purchase of Whole Foods for $13.4 billion, is eying to enter the pharmaceutical delivery business.
comments powered by Disqus
Follow RTT